The treatment of DSS-induced colitis in CD69−/− mice with the mixture of Abs that neutralize CCL-1, CXCL-10 and CCL-19 did not affect the accelerated body weight loss (Fig. 5A), but it reduced significantly the histopathological severity of the disease (Fig. 5B). This evidence concerns the gene CCL19 and colitis.